|
|
Article: Herpes simplex virus and radiation cause regression in hepatoma.
- Article from:
- Gene Therapy Weekly
- Article date:
- April 18, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 APR 18 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A new vaccine candidate has been shown to cause tumor regression in experimental hepatoma, or liver cancer.
Researchers in the U.S. say animal model experiments have demonstrated that a recombinant strain of herpes simplex virus (HSV), R7020, causes tumors to recede when combined with ionizing radiation in animals with grafted human hepatoma.
"The HSV recombinant virus R7020 is an attenuated virus designed as a candidate for immunization against both HSV-1 and HSV-2 infections," R. Weichselbaum and coauthors, University of Chicago, noted recently, adding, "It was ...